Skip to content
Search

Latest Stories

PDA 'Locum Matters' event highlights employer pressure tactics on rates

PDA 'Locum Matters' event highlights employer pressure tactics on rates
PDA Locum Members Address Key Issues at 'Locum Matters' Event organised virtually called 'Locum Matters'

At the recent 'Locum Matters' online event held on June 25, 2024, members of the Pharmacists' Defence Association (PDA) discussed critical issues facing locum pharmacists, with a disturbing trend taking center stage: employers pressuring locum pharmacists to accept lower rates under the threat of potential pharmacy closures.

The event, organised in response to feedback from PDA locum members, addressed a range of significant topics including training for the recent Pharmacy First Services, respect for professional autonomy, and the need for adequate rest breaks.


However, the issue of rate pressure and pharmacy closures was a focal point.

Several locum pharmacists reported that some employers were leveraging the possibility of pharmacy closures to coerce them into working for lower pay.

This unethical practice has raised alarm within the locum community, highlighting the precarious working conditions many face.

Paul Day, Director of Membership & Communities at the PDA, provided a detailed presentation on locum rates, agency working, and the legalities surrounding cartels.

He also covered the rights of employees, workers, and the self-employed, and the implications of different employment statuses.

Una O’Farrell, PDA National Officer and pharmacist, discussed the opportunities for locum pharmacists to actively participate in the PDA.

She shared successful examples of campaigning and trade union activities from other PDA members, emphasising the power of solidarity.

O’Farrell reiterated that the PDA is the independent certified union for all pharmacists, including locums, and that many issues raised impact the entire profession.

During a FAQ session, participants learned about political lobbying and campaigning on issues such as supervision, staffing, pay, and wellbeing.

PDA National Officer and locum pharmacist, Paul Flynn, urged members to volunteer as PDA Representatives, engage in training, and join the PDA Locum Task Force.

He emphasised the potential for collective action to effect change within the sector.

Flynn stated, “The PDA has an excellent trade union training programme for all reps, including locum members who have stepped up to the challenge ahead.

"I look forward to bringing the PDA Locum Task Force together to support them in prioritising their issues and building their campaigning activity.

"Many issues raised by locum members, such as the Pharmacy First Service, workload, wellbeing, and health and safety, are also faced by all pharmacists.

The PDA is well-positioned to help locum members join forces with pharmacists from other sectors to address these issues with employers and new MPs.”

Sidney, a PDA Locum Representative, shared his experience, saying, “I enjoy being a PDA Locum Rep and feel it is important to be part of leading change.

"Being a rep has enabled me to network with peers across pharmacy sectors and gain valuable information and knowledge.

"From this meeting, I hope we can raise awareness of the challenges locum pharmacists face and unite to amplify our voice through the PDA.”

Collette Bradford, PDA Director for Organising and Engagement, facilitated the event and remarked, “There is strength in locum members understanding their worth and supporting each other on important matters.

"The PDA is the union for all pharmacists, and we look forward to working closely with our PDA Locum Reps Task Force and the broader locum membership to address the issues they have raised.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less